
Investors should maintain exposure to Alphabet Inc. (GOOGL) as internal AI adoption compresses product development timelines from two years down to three months, unlocking massive operational leverage. Moderna, Inc. (MRNA) represents an asymmetric upside opportunity as high-performance computing and AI-driven modeling accelerate multi-billion-dollar therapeutic pipelines in cancer and mRNA treatments. In private markets, prioritize autonomous agent developers like xAI and OpenAI, which are capturing high-margin revenue through enterprise workflows and premium consumer subscriptions reaching $300 per month. Within early-stage technology, target Consumer AI & Experience Platforms like Suno and ElevenLabs that drive strong user monetization around personalized entertainment and emotional connection. For corporate software investments, favor a hybrid enterprise AI strategy that utilizes top-tier frontier models from Anthropic and OpenAI for high-ROI problem-solving while deploying cost-effective open-weight models for routine back-office tasks.

By Andreessen Horowitz
The a16z Podcast discusses tech and culture trends, news, and the future – especially as ‘software eats the world’. It features industry experts, business leaders, and other interesting thinkers and voices from around the world. This podcast is produced by Andreessen Horowitz (aka “a16z”), a Silicon Valley-based venture capital firm. Multiple episodes are released every week; visit a16z.com for more details and to sign up for our newsletters and other content as well!